. Author manuscript; available in PMC: 2015 Feb 24.

Published in final edited form as: Ann Surg Oncol. 2009 Mar 12;16(6):1606–1611. doi: 10.1245/s10434-009-0402-z

TABLE 3.

Proportion of patients who had breast-conserving surgery as their final surgical procedure

Size at presentation (cm)	Final outcome BCS (expressed as proportion of patients with attempted BCS)			Final outcome BCS (expressed as proportion of all patients)
Size at presentation (cm)	Neoadjuvant chemotherapy	Surgery first	p-Value	Neoadjuvant chemotherapy	Surgery first	p-Value
0–2.0	2/3 (66.6%)	59/66 (89.4%)	0.31	2/3 (33.3%)	59/106 (55.7%)	1.00
2.1–4.0	7/11 (63.6%)	16/19 (84.2%)	0.37	7/33 (21.2%)	16/48 (33.3%)	0.32
4.1–6.0	4/8 (50%)	2/4 (50%)	1.00	4/20 (20%)	2/19 (10.5%)	0.66
> 6.0	1/3 (33.3%)	1/2 (50%)	1.00	1/23 (4.3%)	1/8 (12.5%)	0.46
All patients	14/25 (56%)	78/91 (85.7%)	0.004	14/82 (17.1%)	78/181 (43.1%)	< 0.001